HIV-1 Genotyping Targeting Integrase - Perspectives on Surveillance of Antiretroviral Drug Resistance

Explore the latest developments in HIV-1 genotyping and drug resistance surveillance in this 41-minute panel presentation webinar. Delve into the WHO HIV Drug Resistance Report for 2021, focusing on surveillance efforts in South Africa and a new surveillance tool targeting protease, reverse-transcriptase, and integrase inhibitors. Gain insights from Dr. Kim Steegen on HIV-1 drug resistance prevalence, learn about the ExatypeTM Sanger HIV genotyping data analysis solution from Dr. Natasha Wood, and discover the design and validation of a new genotyping kit presented by Dr. Stephen Williams. Participate in a panel discussion addressing current challenges, lessons learned, and future possibilities in HIV evolution research. Earn PACE credits by watching the webinar and following the provided instructions.